Carfilzomib in relapsed/refractory multiple myeloma patients – real world evidence – experiences of the Croatian cooperative group for hematologic diseases (KROHEM)
This is the first study to analyze clinical outcomes of RRMM patients treated with carfilzomib-based regimens in Croatia. Carfilzomib-based regimens showed substantial efficacy and acceptable toxicity in RRMM, especially in earlier treatment lines and triplet combinations.
Authors
- Goran Rinčić
- Milan Vujčić
- Vlatka Periša (ORCID: https://orcid.org/0000-0003-4801-1270)
- Barbara Dreta
- Marin Šimunić
- Toni Valković (ORCID: https://orcid.org/0000-0001-6083-8815)
- Petra Berneš
- Fran Petričević
- Klara Brčić (ORCID: https://orcid.org/0000-0002-1719-1195)
- Martina Morić Perić
- Martina Sedinić Lacko
- Luka Kuzat
- Mario Piršić
- Josip Batinic
- Davor Galušić (ORCID: https://orcid.org/0000-0001-5485-8529)
- Ivan Krečak (ORCID: https://orcid.org/0000-0002-8642-305X)
- Dubravka Županić Krmek
- Sandra Bašić‐Kinda (ORCID: https://orcid.org/0000-0001-5850-180X)
- Dragana Grohovac
- Karla Mišura Jakobac (ORCID: https://orcid.org/0000-0001-7353-8811)
- Delfa Radić Krišto
- Ivan Zekanović
- Jasminka Sinčić-Petričević
- Hrvoje Holik (ORCID: https://orcid.org/0000-0002-3767-5779)
- ilenia Romić
Institutions
- University Hospital Centre Zagreb (HR)
- University of Rijeka (HR)
- University of Dubrovnik (HR)
- Juraj Dobrila University of Pula (HR)
- University Hospital Dubrava (HR)
- Klinička bolnica "Sveti Duh" (HR)
- Polytechnic of Međimurje in Čakovec (HR)
- Klinička bolnica Merkur (HR)
- Sisters of Charity Hospital (HR)
- Klinički bolnički centar Osijek (HR)
- Klinički Bolnički Centar Split (HR)
- University of Slavonski Brod (HR)
- Polytechnic Pula (HR)
- Šibenik University of Applied Sciences (HR)
- University of Osijek (HR)
- University of Zadar (HR)
- University of Split (HR)
Publication Details
- Journal
- Cancer Treatment and Research Communications
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.ctarc.2025.100912
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00